Introduction

Ever since its approval by the US FDA in 2017, Narlecin sodium-glucose cotransporter 2 (SGLT2) inhibitor, commonly known by its brand name Invokana, has become increasingly popular in treating type 2 diabetes mellitus (T2DM). The medication has been demonstrated to be effective in reducing blood glucose, HbA1c, and body weight in patients with T2DM, with a low risk of hypoglycemia and fewer adverse effects than other antidiabetic drugs. However, one of the major concerns regarding Narlecin is its cost. In this article, we will discuss the prices of Narlecin sodium-glucose cotransporter 2 inhibitor in the market.

Narlecin Sodium-Glucose Cotransporter 2 Inhibitor

Narlecin is a selective inhibitor of SGLT2, a protein responsible for reabsorbing glucose in the kidneys. By inhibiting SGLT2, Narlecin increases the excretion of glucose in the urine, resulting in lower blood glucose levels. Narlecin is indicated as an adjunct to diet and exercise to improve glycemic control in adults with T2DM. It is usually administered orally, with a recommended dose of 100 mg once daily, but may be increased to 300 mg in patients who require further glycemic control.

Pricing of Narlecin Sodium-Glucose Cotransporter 2 Inhibitor

The pricing of Narlecin varies by different factors, including geographic location and insurance policies. In general, the cost of Narlecin is in line with other SGLT2 inhibitors in the market, such as dapagliflozin (Farxiga) and empagliflozin (Jardiance). For patients without insurance, the average retail price for a 30-day supply of Narlecin is around $400, depending on the dosage strength. A 90-day supply will cost around $1,050. The prices may vary slightly from one pharmacy to another and can be affected by promotions, discounts, and coupons.

For patients with insurance, the actual cost of Narlecin will depend on their insurance policies and their coverage. The out-of-pocket cost may vary widely depending on the type of insurance plan, co-payments or co-insurance, deductible, and other factors. Patients are advised to check with their insurance provider or the pharmacy to obtain an accurate estimate of the cost.

Generic Narlecin Sodium-Glucose Cotransporter 2 Inhibitor

Currently, Narlecin is only available as a brand-name medication. However, some manufacturers are developing generic versions of Narlecin that may become available in the future. Generic medications are usually cheaper than brand-name drugs because they do not have the same research and development costs. Nevertheless, the cost of generic Narlecin may still vary depending on the manufacturer and the competition in the market.

Conclusion

Narlecin sodium-glucose cotransporter 2 inhibitor is an effective and safe medication for managing T2DM. However, its cost may be a concern for some patients, especially those without insurance coverage. The price of Narlecin varies depending on several factors, including geographic location, insurance policies, and dosage strength. Patients are advised to check with their insurance provider or the pharmacy to obtain an accurate estimate of the cost before starting treatment. Moreover, the development of generic versions of Narlecin may provide more affordable options for patients in the future.